EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating Serum Cell-Free Mitochondrial DNA in Amyotrophic Lateral Sclerosis

Giada Zanini iD, Ilaria Martinelli, Giorgia Sinigaglia, Elisabetta Zucchi, Federico Banchelli iD, Cecilia Simonini iD, Giulia Gianferrari iD, Andrea Ghezzi, Jessica Mandrioli iD, Marcello Pinti iD

Cells · 2025

DOI: 10.3390/cells14181433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Giada Zanini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Cell-Free Nucleic Acids, DNA, Mitochondrial. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-Next Generation EU, Mission 6, Component 2, Fondazione Cassa di Risparmio di Modena, European Union—Next Generation EU, Mission 6, Component 2.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction is a key pathological hallmark in amyotrophic lateral sclerosis (ALS), yet the role of circulating cell-free mitochondrial DNA (Cf-mtDNA) as a biomarker remains unclear. This study aimed to investigate serum Cf-mtDNA levels in ALS patients compared to healthy controls and explore its associations with disease biomarkers, clinical progression, and survival. We conducted a case–control study measuring Cf-mtDNA levels in serum samples from 54 ALS patients and 36 age- and sex-matched healthy controls using quantitative droplet digital PCR. Correlations between Cf-mtDNA levels and clinical features, neurofilament concentrations, inflammatory indices, and survival were assessed. The average Cf-mtDNA level in ALS patients was 2,426,315 copies/mL of serum (IQR: 865000–2475000), compared to 1,885,667 copies/mL of serum (IQR: 394250–2492500) in controls (p = 0.308). ROC analysis yielded an AUC of 0.595 (95% CI: 0.468–0.721), indicating very limited discriminant ability. Cf-mtDNA levels were inversely correlated with serum creatinine concentrations (r = –0.335, p = 0.018), but showed no significant associations with ALS phenotype, disease staging, neurofilaments, inflammatory indices, or survival. These findings suggest that, in a predominantly sporadic ALS cohort, serum Cf-mtDNA may not serve as a standalone diagnostic or prognostic biomarker, in contrast to previous reports. Methodological differences, cohort composition, and genetic heterogeneity may account for these discrepancies. Our results underscore the importance of further large-scale, longitudinal studies incorporating genetic stratification and multi-biomarker approaches to better elucidate the role of Cf-mtDNA in ALS pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisCell-Free Nucleic AcidsDNA, MitochondrialHumansMaleFemaleMiddle AgedCase-Control StudiesBiomarkersAgedAdult

Stichwörter der Autor:innen

amyotrophic lateral sclerosisbiomarkercirculating cell-free mitochondrial DNAmitochondrianeuroinflammationoxidative stress

Substanzen

Cell-Free Nucleic AcidsDNA, MitochondrialBiomarkers

Autor:innen und Institutionen

  • Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
  • Department of Neurosciences, Ospedale Civile di Baggiovara, Azienda Ospedaliero-Universitaria di Modena, 41126 Modena, Italy.
  • Neuroscience PhD Program, Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
  • Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.

ORCID-Profile: Giada Zanini, Federico Banchelli, Cecilia Simonini, Giulia Gianferrari, Jessica Mandrioli, Marcello Pinti

Förderung

  • European Union-Next Generation EU, Mission 6, Component 2
  • Fondazione Cassa di Risparmio di Modena
  • European Union—Next Generation EU, Mission 6, Component 2
  • project “INSPIRER”

Zitieren

APA

Zanini, G., Martinelli, I., Sinigaglia, G., Zucchi, E., Banchelli, F., Simonini, C., Gianferrari, G., Ghezzi, A., Mandrioli, J., & Pinti, M. (2025). Circulating Serum Cell-Free Mitochondrial DNA in Amyotrophic Lateral Sclerosis. Cells. https://doi.org/10.3390/cells14181433

Vancouver

Zanini G, Martinelli I, Sinigaglia G, Zucchi E, Banchelli F, Simonini C, et al. Circulating Serum Cell-Free Mitochondrial DNA in Amyotrophic Lateral Sclerosis. Cells. 2025. doi:10.3390/cells14181433

BibTeX
@article{Zanini2025,
  author = {Zanini, Giada and Martinelli, Ilaria and Sinigaglia, Giorgia and Zucchi, Elisabetta and Banchelli, Federico and Simonini, Cecilia and Gianferrari, Giulia and Ghezzi, Andrea and Mandrioli, Jessica and Pinti, Marcello},
  title = {Circulating Serum Cell-Free Mitochondrial DNA in Amyotrophic Lateral Sclerosis},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14181433}
}
Kostenlos starten →